Publication | Open Access

Bispecific Her2 × cotinine antibody in combination with cotinine–(histidine)2–iodine for the pre-targeting of Her2-positive breast cancer xenografts

Tumor BiologyBreast OncologyMedicineImmunologyPharmacologyBreast CancerImmunotherapeuticsTumor TargetingCancer TreatmentOncologyCancer Research